Use of Complementary or Alternative Medicine Practices by Women at Increased Risk for Breast Cancer
18 Years
N/A
Female
Breast Cancer
Trial Information
Use of Complementary or Alternative Medicine Practices by Women at Increased Risk for Breast Cancer
OBJECTIVES: I. Determine the prevalence of complementary or alternative medicine (CAM)
practices among adult women who are enrolled in the Risk Assessment Clinic at the National
Naval Medical Center Breast Care Center and are found to be at increased risk for developing
breast cancer. II. Correlate the use of CAM with individual risk for breast cancer. III.
Define the types of CAM practices used by this study population. IV. Identify reasons why
this study population is using CAM.
OUTLINE: Patients are stratified according to prevalence of complementary and alternative
medicine practices (enteral/parenteral vs psychologic/neurologic). Patients complete a
Personal Risk Assessment form, pre-test/post-test knowledge questionnaires, and a survey
questionnaire.
PROJECTED ACCRUAL: A total of 102 patients will be accrued for this study within
approximately 2 years.
Inclusion Criteria
DISEASE CHARACTERISTICS: Enrolled in the Risk Assessment Clinic (RAC) of the National
Naval Medical Center and found to be at increased risk for breast cancer based on at least
one of the following: Estimated risk of at least 1.7% for developing breast cancer over
the next 5 years, as determined by the Breast Cancer Risk Assessment Tool (BCRAT) Prior
history of lobular carcinoma in situ or ductal carcinoma in situ Family history of breast
or ovarian cancer consistent with autosomal dominant pattern of inheritance or empirically
elevated risk of breast cancer based on a single first- or second-degree relative with
breast or ovarian cancer Must have attended the RAC education session within past 3-6
months Hormone receptor status: Not specified
PATIENT CHARACTERISTICS: Age: 18 and over Sex: Female Menopausal status: Not specified
Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not
specified Hepatic: Not specified Renal: Not specified Other: No other prior cancer except
ductal carcinoma in situ or basal cell carcinoma Able to read and understand English
PRIOR CONCURRENT THERAPY: Not specified
Type of Study:
Interventional
Study Design:
Primary Purpose: Prevention
Principal Investigator
Paula Glauber, RN
Investigator Role:
Study Chair
Investigator Affiliation:
National Cancer Institute (NCI)
Authority:
United States: Federal Government
Study ID:
000039
NCT ID:
NCT00020098
Start Date:
June 2000
Completion Date:
September 2001
Related Keywords:
- Breast Cancer
- breast cancer
- Breast Neoplasms
Name | Location |
|---|---|
| National Naval Medical Center | Bethesda, Maryland 20889 |
| Medicine Branch | Bethesda, Maryland 20892 |
